Revisions Tourmaline Bio, Inc.

Equities

TRML

US89157D1054

Real-time Estimate Cboe BZX 10:11:32 2024-07-11 am EDT 5-day change 1st Jan Change
14.34 USD +4.48% Intraday chart for Tourmaline Bio, Inc. +13.09% -45.87%

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. TRML Stock
  4. Revisions Tourmaline Bio, Inc.